Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. Sinitsyn (Moscow, Russian Federation), S. Borisov (Moscow, Russian Federation), E. Belilovskiy (Moscow, Russian Federation), M. Matveeva (Moscow, Russian Federation), S. Rostovtsev (Moscow, Russian Federation). Long-term effectiveness of surgery treatment of TB patients. 503

Member's Comments

No comment yet.

Related content which might interest you: The effect of resection surgery on long-term treatment outcomes of patients with MDR/XDR-TB Source: International Congress 2017 – Treatment of multi-drug-resistant tuberculosis (MDRTB): where are we now? Year: 2017 Clinical management improves the treatment outcome of MDR-TB patients Source: International Congress 2017 – Paediatric TB: MDRTB (II) Year: 2017 Treatment outcomes for XDR TB patients with surgery Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis Year: 2007 Long-term results of a surgical treatment in patients with thymomas Source: Eur Respir J 2003; 22: Suppl. 45, 368s Year: 2003 MDR/XDR-TB treatment outcome Source: Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance Year: 2009 Outcomes of drug-resistant TB cases undergoing bedaquiline (BQ)-treatment and adjunctive surgery Source: International Congress 2018 – Drug-resistant tuberculosis Year: 2018 Long-term results of treatment with bedaquiline in patients with drug-resistant tuberculosis Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020 Long-term treatment with infliximab in patients with sarcoidosis Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders Year: 2011 Efficiency of treatment regimens for chronic tuberculosis patients Source: Eur Respir J 2003; 22: Suppl. 45, 519s Year: 2003 Long-term outcome and safety of prolonged bedaquiline treatment for multidrug-resistant tuberculosis Source: Eur Respir J , 49 (3) 1601799; DOI: 10.1183/13993003.01799-2016 Year: 2017 Impact of pre-treatment duration by first line drugs on treatment outcomes of patients with MDR-TB Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015 Long-term outcomes of directly observed therapy in a low tuberculosis incidence setting Source: Annual Congress 2008 - Epidemiological and clinical aspects of tuberculosis control Year: 2008 Retreatment of tuberculosis patients after the treatment interruption Source: Eur Respir J 2006; 28: Suppl. 50, 506s Year: 2006 Long-term mortality assessment of multidrug-resistant tuberculosis patients treated with delamanid Source: Eur Respir J 2015; 45: 1498-1501 Year: 2015 A choice of regimen improves completion for patients with latent TB infection Source: Breathe 2008; 4: 366 Year: 2008 Our clinical experience in surgical therapy of patients with bronchiectasis Source: Eur Respir J 2002; 20: Suppl. 38, 344s Year: 2002 Impact of XDR-TB on treatment outcome of MDR-TB patients with standardized regimens Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis Year: 2008 Factors affecting the efficacy of treatment of MDR/XDR TB patients receiving bedaquiline Source: International Congress 2019 – Tuberculosis: a public health approach Year: 2019